Ozempic, whose active ingredient is semaglutide, is designed to mimic the beneficial actions of natural GLP-1
Tom Gavin Fact-Checker Tom Gavin joined Everyday Health as copy chief in 2022 after a lengthy stint as a freelance copy editor
Back Trapp, S, Brierley, DI (29 July 2021) 'Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment' British Journal of Pharmacology
Reduces insulin resistance : HOMA-IR measurements decrease as early as two weeks after treatment begins 5
Low-grade chronic inflammation is now known to be a major contributor to a myriad of conditions, including cancer, obesity and diabetes (Underwerth)
If the medications are discontinued, questions as to what the health ramifications to those individuals who cannot afford out-of-pocket coverage must be considered